Literature DB >> 16436389

The time for tobacco industry sponsored PREP evaluation has arrived.

T Eissenberg.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16436389      PMCID： PMC2563621          DOI： 10.1136/tc.2005.014381

Source DB:  PubMed          Journal:  Tob Control        ISSN： 0964-4563            Impact factor:   7.552


× No keyword cloud information.
  23 in total

1.  Three soliloquies on tobacco industry funding of university research.

Authors:  L T Kozlowski
Journal:  Tob Control       Date:  2003-06       Impact factor: 7.552

2.  Reducing tobacco harm: research challenges and issues.

Authors:  Dorothy K Hatsukami; John Slade; Neal L Benowitz; Gary A Giovino; Ellen R Gritz; Scott Leischow; Kenneth E Warner
Journal:  Nicotine Tob Res       Date:  2002       Impact factor: 4.244

3.  Hazardous effects of tobacco industry funding.

Authors:  M Parascandola
Journal:  J Epidemiol Community Health       Date:  2003-08       Impact factor: 3.710

4.  Chasing the dollar: why scientists should decline tobacco industry funding.

Authors:  R E Malone; L A Bero
Journal:  J Epidemiol Community Health       Date:  2003-08       Impact factor: 3.710

5.  Smoker and ex-smoker reactions to cigarettes claiming reduced risk.

Authors:  S Shiffman; J L Pillitteri; S L Burton; M E Di Marino
Journal:  Tob Control       Date:  2004-03       Impact factor: 7.552

6.  Tobacco harm reduction: promise and perils.

Authors:  Kenneth E Warner
Journal:  Nicotine Tob Res       Date:  2002       Impact factor: 4.244

7.  Long-term effects of the Eclipse cigarette substitute and the nicotine inhaler in smokers not interested in quitting.

Authors:  Karl Olov Fagerström; John R Hughes; Peter W Callas
Journal:  Nicotine Tob Res       Date:  2002       Impact factor: 4.244

8.  Tobacco harm reduction: a call to address the ethical dilemmas.

Authors:  Brion J Fox; Joanna E Cohen
Journal:  Nicotine Tob Res       Date:  2002       Impact factor: 4.244

9.  Tobacco specific nitrosamines and potential reduced exposure products for smokers: a preliminary evaluation of Advance.

Authors:  A B Breland; M C Acosta; T Eissenberg
Journal:  Tob Control       Date:  2003-09       Impact factor: 7.552

10.  Quantitative comparisons between a nicotine delivery device (Eclipse) and conventional cigarette smoking.

Authors:  Eun M Lee; Jennifer L Malson; Eric T Moolchan; Wallace B Pickworth
Journal:  Nicotine Tob Res       Date:  2004-02       Impact factor: 4.244
View more
  2 in total

1.  A clinical laboratory model for evaluating the acute effects of electronic "cigarettes": nicotine delivery profile and cardiovascular and subjective effects.

Authors:  Andrea R Vansickel; Caroline O Cobb; Michael F Weaver; Thomas E Eissenberg
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-07-20       Impact factor: 4.254

2.  Criteria for evaluating tobacco control research funding programs and their application to models that include financial support from the tobacco industry.

Authors:  J E Cohen; M Zeller; T Eissenberg; M Parascandola; R O'Keefe; L Planinac; S Leischow
Journal:  Tob Control       Date:  2009-02-24       Impact factor: 7.552
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.